Hyperexpression of tumor necrosis factor receptor 2 inhibits differentiation of myeloid‐derived suppressor cells by instigating apolarity during ageing

Documenti analoghi

• Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
  di: Shiqi Li, et al.
  Pubblicazione: (2024)
• UFMylation System: Biological Functions, Molecular Mechanisms, Diseases, and Drug Discovery
  di: Huiyan Li, et al.
  Pubblicazione: (2025)
• Phospholysine phosphohistidine inorganic pyrophosphate phosphatase suppresses insulin‐like growth factor 1 receptor expression to inhibit cell adhesion and proliferation in gastric cancer
  di: Zihao Zhang, et al.
  Pubblicazione: (2024)
• Epidermal growth factor receptor‑targeted antibody nimotuzumab combined with chemoradiotherapy improves survival in patients with locally advanced head and neck squamous cell carcinoma: a propensity score matching real‐world study
  di: Peng Zhang, et al.
  Pubblicazione: (2024)
• Hypertrophic Scarring and Keloids: Epidemiology, Molecular Pathogenesis, and Therapeutic Interventions
  di: Xiaowan Fang, et al.
  Pubblicazione: (2025)